Literature DB >> 11809706

Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells.

Nilamani Jena1, Ming Deng, Eva Sicinska, Piotr Sicinski, George Q Daley.   

Abstract

Chronic myeloid leukemia is caused by the tyrosine kinase oncoprotein BCR/ABL. Using oligonucleotide arrays to assay mRNAs at different phases of the cell cycle in BCR/ABL-transformed cells, we found that cyclin D2 mRNA was constitutively expressed at high levels throughout the cell cycle, a pattern confirmed by immunoblotting of protein lysates. Bone marrow cells from cyclin D2-deficient strains of mice failed to proliferate in response to infection with a retrovirus carrying BCR/ABL and failed to generate transformed lymphoid cell lines in vitro. These results establish that BCR/ABL promotes cell cycle progression by altering expression of cyclin D2 and that cyclin D2 induction plays a critical role in proliferation of hematopoietic cells by BCR/ABL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809706

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.

Authors:  Ildiko Györy; Sören Boller; Robert Nechanitzky; Elizabeth Mandel; Sebastian Pott; Edison Liu; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2012-03-19       Impact factor: 11.361

2.  Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways.

Authors:  Dai Horiuchi; Noelle E Huskey; Leonard Kusdra; Lara Wohlbold; Karl A Merrick; Chao Zhang; Katelyn J Creasman; Kevan M Shokat; Robert P Fisher; Andrei Goga
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-03       Impact factor: 11.205

3.  A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation.

Authors:  S Prabhu; D Saadat; M Zhang; L Halbur; J P Fruehauf; S T Ong
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

4.  Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.

Authors:  Bonan Lin; Xiaomeng Zhou; Shuye Lin; Xiaoyue Wang; Meiying Zhang; Baoping Cao; Yan Dong; Shuai Yang; Ji Ming Wang; Mingzhou Guo; Jiaqiang Huang
Journal:  J Mol Med (Berl)       Date:  2017-08-26       Impact factor: 4.599

5.  Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations.

Authors:  S Wong; J McLaughlin; D Cheng; C Zhang; K M Shokat; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

6.  Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL.

Authors:  Iris Appelmann; Cory D Rillahan; Elisa de Stanchina; Gregory Carbonetti; Chong Chen; Scott W Lowe; Charles J Sherr
Journal:  Blood       Date:  2014-12-12       Impact factor: 22.113

7.  Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.

Authors:  Anna M Eiring; Paolo Neviani; Ramasamy Santhanam; Joshua J Oaks; Ji Suk Chang; Mario Notari; William Willis; Carlo Gambacorti-Passerini; Stefano Volinia; Guido Marcucci; Michael A Caligiuri; Gustavo W Leone; Danilo Perrotti
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

8.  Intrauterine programming of fetal islet gene expression in rats--effects of maternal protein restriction during gestation revealed by proteome analysis.

Authors:  T Sparre; B Reusens; H Cherif; M R Larsen; P Roepstorff; S J Fey; P Mose Larsen; C Remacle; J Nerup
Journal:  Diabetologia       Date:  2003-09-12       Impact factor: 10.122

9.  Transcriptional dysregulation in a transgenic model of Parkinson disease.

Authors:  Talene A Yacoubian; Ippolita Cantuti-Castelvetri; Bérengère Bouzou; Georgios Asteris; Pamela J McLean; Bradley T Hyman; David G Standaert
Journal:  Neurobiol Dis       Date:  2007-11-28       Impact factor: 5.996

10.  Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.

Authors:  Ryan A Metcalf; Shuchun Zhao; Matthew W Anderson; Zhi Shun Lu; Ilana Galperin; Robert J Marinelli; Athena M Cherry; Izidore S Lossos; Yasodha Natkunam
Journal:  Mod Pathol       Date:  2010-01-08       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.